Back to top

Tale of the Tape

Zacks Equity Research

Enzo Biochem (ENZ) Looks Good: Stock Adds 11% in Session
October 17, 2016

ENZ EXEL

Trades from $3

Enzo Biochem Inc. (ENZ - Free Report) was a big mover last session, as its shares rose a little more than 11% on the day. The move came after the company reported strong results for the fourth quarter and fiscal year ended July 31, 2016. This led to far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $4.92 to $5.48 in the past one-month time frame.

None of the estimates for this stock were revised over the past 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Enzo Biochem currently carries a Zacks Rank #3 (Hold).

A better-ranked stock in the med-biomed/gene space is Exelixis, Inc. (EXEL - Free Report) , which sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is ENZ going up? Or down? Predict to see what others think: Up or Down

Confidential from Zacks

Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>